Outcomes Associated With Intensive Care and Organ Support Among Patients With COVID-19: A Systematic Review and Meta-Analysis.


Journal

Military medicine
ISSN: 1930-613X
Titre abrégé: Mil Med
Pays: England
ID NLM: 2984771R

Informations de publication

Date de publication:
20 03 2023
Historique:
received: 31 01 2022
revised: 03 05 2022
accepted: 12 05 2022
pubmed: 1 6 2022
medline: 23 3 2023
entrez: 31 5 2022
Statut: ppublish

Résumé

Accurate accounting of coronavirus disease 2019 (COVID-19) critical care outcomes has important implications for health care delivery. We aimed to determine critical care and organ support outcomes of intensive care unit (ICU) COVID-19 patients and whether they varied depending on the completeness of study follow-up or admission time period. We conducted a systematic review and meta-analysis of reports describing ICU, mechanical ventilation (MV), renal replacement therapy (RRT), and extracorporeal membrane oxygenation (ECMO) mortality. A search was conducted using PubMed, Embase, and Cochrane databases.We included English language observational studies of COVID-19 patients, reporting ICU admission, MV, and ICU case fatality, published from December 1, 2019 to December 31, 2020. We excluded reports of less than 5 ICU patients and pediatric populations. Study characteristics, patient demographics, and outcomes were extracted from each article. Subgroup meta-analyses were performed based on the admission end date and the completeness of data. Of 6,778 generated articles, 145 were retained for inclusion (n = 60,357 patients). Case fatality rates across all studies were 34.0% (95% CI = 30.7%, 37.5%, P < 0.001) for ICU deaths, 47.9% (95% CI = 41.6%, 54.2%, P < 0.001) for MV deaths, 58.7% (95% CI = 50.0%, 67.2%, P < 0.001) for RRT deaths, and 43.3% (95% CI = 31.4%, 55.4%, P < 0.001) for extracorporeal membrane oxygenation deaths. There was no statistically significant difference in ICU and organ support outcomes between studies with complete follow-up versus studies without complete follow-up. Case fatality rates for ICU, MV, and RRT deaths were significantly higher in studies with patients admitted before April 31st 2020. Coronavirus disease 2019 critical care outcomes have significantly improved since the start of the pandemic. Intensive care unit outcomes should be evaluated contextually (study quality, data completeness, and time) for the most accurate reporting and to effectively guide mortality predictions.

Sections du résumé

BACKGROUND
Accurate accounting of coronavirus disease 2019 (COVID-19) critical care outcomes has important implications for health care delivery.
RESEARCH QUESTION
We aimed to determine critical care and organ support outcomes of intensive care unit (ICU) COVID-19 patients and whether they varied depending on the completeness of study follow-up or admission time period.
STUDY DESIGN AND METHODS
We conducted a systematic review and meta-analysis of reports describing ICU, mechanical ventilation (MV), renal replacement therapy (RRT), and extracorporeal membrane oxygenation (ECMO) mortality. A search was conducted using PubMed, Embase, and Cochrane databases.We included English language observational studies of COVID-19 patients, reporting ICU admission, MV, and ICU case fatality, published from December 1, 2019 to December 31, 2020. We excluded reports of less than 5 ICU patients and pediatric populations. Study characteristics, patient demographics, and outcomes were extracted from each article. Subgroup meta-analyses were performed based on the admission end date and the completeness of data.
RESULTS
Of 6,778 generated articles, 145 were retained for inclusion (n = 60,357 patients). Case fatality rates across all studies were 34.0% (95% CI = 30.7%, 37.5%, P < 0.001) for ICU deaths, 47.9% (95% CI = 41.6%, 54.2%, P < 0.001) for MV deaths, 58.7% (95% CI = 50.0%, 67.2%, P < 0.001) for RRT deaths, and 43.3% (95% CI = 31.4%, 55.4%, P < 0.001) for extracorporeal membrane oxygenation deaths. There was no statistically significant difference in ICU and organ support outcomes between studies with complete follow-up versus studies without complete follow-up. Case fatality rates for ICU, MV, and RRT deaths were significantly higher in studies with patients admitted before April 31st 2020.
INTERPRETATION
Coronavirus disease 2019 critical care outcomes have significantly improved since the start of the pandemic. Intensive care unit outcomes should be evaluated contextually (study quality, data completeness, and time) for the most accurate reporting and to effectively guide mortality predictions.

Identifiants

pubmed: 35639913
pii: 6593978
doi: 10.1093/milmed/usac143
pmc: PMC9384097
doi:

Types de publication

Meta-Analysis Systematic Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

541-546

Informations de copyright

Published by Oxford University Press on behalf of the Association of Military Surgeons of the United States 2022. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Auteurs

Sahar Leazer (S)

Department of Medicine, Uniformed Services University of Health Sciences, Bethesda, MD 20814, USA.
The Metis Foundation, San Antonio, TX 78216, USA.

Jacob Collen (J)

Department of Medicine, Uniformed Services University of Health Sciences, Bethesda, MD 20814, USA.

Karl Alcover (K)

Department of Medicine, Uniformed Services University of Health Sciences, Bethesda, MD 20814, USA.

Erin Tompkins (E)

Department of Medicine, Uniformed Services University of Health Sciences, Bethesda, MD 20814, USA.

Shiva Ambardar (S)

Department of Medicine, Uniformed Services University of Health Sciences, Bethesda, MD 20814, USA.

Rhonda J Allard (RJ)

Department of Medicine, Uniformed Services University of Health Sciences, Bethesda, MD 20814, USA.

Brian Foster (B)

Walter Reed National Military Medical Center, Bethesda, MD 20814, USA.

Ryan McNutt (R)

Department of Medicine, Uniformed Services University of Health Sciences, Bethesda, MD 20814, USA.

Matthew Leon (M)

Department of Medicine, Uniformed Services University of Health Sciences, Bethesda, MD 20814, USA.

Zachary Haynes (Z)

Walter Reed National Military Medical Center, Bethesda, MD 20814, USA.

Makala Bascome (M)

Walter Reed National Military Medical Center, Bethesda, MD 20814, USA.

Matthias Williams (M)

Walter Reed National Military Medical Center, Bethesda, MD 20814, USA.

Jessica Bunin (J)

Department of Medicine, Uniformed Services University of Health Sciences, Bethesda, MD 20814, USA.

Patrick G O'Malley (PG)

Department of Medicine, Uniformed Services University of Health Sciences, Bethesda, MD 20814, USA.

Lisa K Moores (LK)

Department of Medicine, Uniformed Services University of Health Sciences, Bethesda, MD 20814, USA.

Kevin K Chung (KK)

Department of Medicine, Uniformed Services University of Health Sciences, Bethesda, MD 20814, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH